Atrioventricular Conduction Delay Predicts Impaired Exercise Capacity in Patients with Heart Failure with Reduced

Jakub Stępniewski1, Grzegorz Kopeć1, Wojciech Magoń1

  • 1Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, John Paul II Hospital in Cracow, Cracow, Poland.

Insights

Delayed atrioventricular conduction (AVCD) in heart failure patients with intraventricular conduction disturbances (IVCD) significantly reduces exercise capacity. Longer PR intervals correlate with lower peak oxygen consumption, highlighting AVCD as a key factor in reduced physical function.

Area of Science:

  • Cardiology
  • Exercise Physiology

Background:

  • Atrioventricular conduction delay (AVCD) impairs left ventricular filling and reduces cardiac output.
  • Intraventricular conduction disturbances (IVCD) are common in heart failure with reduced ejection fraction (HFREF).

Purpose of the Study:

  • To evaluate the association between AVCD and exercise capacity in patients with HFREF and coexisting IVCD.
  • To determine if delayed AV conduction affects exercise performance in this specific patient group.

Main Methods:

  • Included patients with stable, chronic HFREF, LVEF <35%, sinus rhythm, and QRS ≥120 ms.
  • Investigated PR interval and peak oxygen consumption (VO2 peak).
  • Utilized multiple regression analysis to adjust for confounders.

Main Results:

  • Patients with longer PR intervals (>200 ms) had significantly lower VO2 peak compared to those with shorter PR intervals (≤200 ms).
  • PR interval, female sex, and ischemic heart disease (IHD) were significant predictors of VO2 peak.
  • The model explained 61% of the variance in VO2 peak.

Conclusions:

  • Delayed AV conduction is a significant contributor to decreased exercise capacity in HFREF patients with IVCD.
  • Addressing AV conduction may be a therapeutic target to improve exercise tolerance in these patients.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.1K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
467
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
692
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.6K